BMC Nephrology is calling for submissions to our Collection on Robotic surgery: clinical application in nephrology.

Robotic surgery has emerged as a transformative approach in the field of nephrology, enabling surgeons to perform complex procedures with enhanced precision and control. With the advent of advanced robotic systems, such as the da Vinci Surgical System, urologists are now able to tackle intricate renal surgeries that were previously deemed challenging with traditional methods. As the technology continues to evolve, its applications in nephrology are expanding, paving the way for innovative surgical practices.

The integration of robotic surgery into nephrology is of critical importance as it addresses the increasing demand for effective and less invasive treatment options for renal diseases. Recent advancements in robotic technology have led to improved dexterity and visualization during surgery, allowing for greater surgical accuracy. The continuous development in this field not only promises enhanced surgical outcomes but also positions robotic surgery as a key player in the future of renal care.

Topics of interest include, but are not limited to:

Applications of da Vinci surgery in nephrology

Innovations in robotic microsurgery

High-tech surgery techniques in renal procedures

Future directions in robotics in medicine

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being) and SDG 9 (Industry, Innovation, and Infrastructure).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Nephrology invites submissions to our Collection on Novel therapies for glomerular diseases.

Glomerular diseases encompass a diverse group of disorders that affect the kidney's filtering units, leading to significant morbidity and mortality. These conditions, which include focal segmental glomerulosclerosis, minimal change disease, and IgA nephropathy, have traditionally posed challenges in terms of effective treatment options. Recent advancements in our understanding of the underlying pathophysiology and the introduction of novel therapeutic modalities, such as targeted biologics and small molecules, present new avenues for intervention. This Collection invites contributions that explore these innovative therapies and their potential to transform the management of glomerular diseases.

Advances in clinical research have led to promising developments, including the successful completion of several clinical trials that evaluate the efficacy of new agents. These therapies not only aim to improve patient outcomes but also focus on personalized treatment approaches that consider individual patient characteristics. By fostering collaboration among researchers, clinicians, and industry partners, we can enhance our understanding and management of these complex conditions. Continued research in this field has the potential to yield groundbreaking discoveries that could redefine treatment paradigms for glomerular diseases.

Topics of interest for this Collection include, but are not limited to:

Novel therapeutic agents in glomerular diseases

Clinical trials of innovative treatments

Impact of new therapies on patient outcomes

Personalized treatment approaches for glomerular disorders

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being and SDG 9: Industry, Innovation, and Infrastructure.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.